Position in APGE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,418,606
New position
Shares Held
18,222
first reported quarter
Ownership
0.024%
of shares outstanding
% of Portfolio
5.87%
of 13F equity value
Holder Rank
#149
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Versor Investments LP holds $5,389,438 across 4 Biotechnology names. APGE ranks #2 (44.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
42,050 | $2,970,832 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
This page
|
18,222 | $2,418,606 | |
| 3 | 76,286 | $0 | |||
| 4 | 25,850 | $0 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,418,606 | 18,222 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||